A carregar...
Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report
BACKGROUND: Hepatosplenic T-cell lymphoma (HSTCL) is a rare subtype of non-Hodgkin’s lymphoma, which has an aggressive clinical course and an extremely poor prognosis. Chidamide is a novel, orally active, benzamide-type histone deacetylase (HDAC) inhibitor that has been used for peripheral T-cell ly...
Na minha lista:
| Publicado no: | World J Clin Cases |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7385602/ https://ncbi.nlm.nih.gov/pubmed/32775395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v8.i14.3122 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|